| Literature DB >> 26625932 |
Amanda F Dempsey1, Julie Maertens2, Brenda Beaty3, Sean T O'Leary4.
Abstract
BACKGROUND: We examined the characteristics of parents using an iPad-based intervention about vaccines, and its impact on vaccination attitudes and behavior.Entities:
Mesh:
Year: 2015 PMID: 26625932 PMCID: PMC4665955 DOI: 10.1186/s13104-015-1721-8
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Demographic characteristics of TeenVaxScene users and their adolescent children
| % (n) | |
|---|---|
| Parent characteristics, n = 54 | |
| Age in years (range, SD) | 41.8 (18–54) |
| Female gender | 66 (31) |
| Marital status | |
| Single | 17 (8) |
| Married/partnership | 76 (36) |
| Divorced/widowed | 7 (3) |
| Hispanic | 10 (5) |
| Race | |
| White | 87 (41) |
| Black | 0 |
| All other choices | 13 (8) |
| Education | |
| <High school | 2 (1) |
| High school graduate | 11 (5) |
| Some college | 86 (41) |
| Prior personal experience with… | |
| Flu | 83 (45) |
| Tetanus | 0 |
| Pertussis | 22 (12) |
| Meningitis | 6 (3) |
| Positive HPV test | 7 (4) |
| Genital warts | 4 (2) |
| Abnormal pap smear | 30 (16) |
| Cervical cancer | 9 (5) |
| None of the above | 13 (7) |
| Prior experience of illness in their adolescent with… | |
| Flu | 63 (34) |
| Tetanus | 0 |
| Pertussis | 13 (7) |
| Meningitis | 2 (1) |
| HPV-related health problems | 0 |
| None of the above | 31 (17) |
| Adolescent characteristics, n = 74a | |
| Adolescent’s age in years (range) | 13.6 (11–17) |
| Female gender | 51 (36) |
| Adolescent’s health | |
| Very good | 69 (51) |
| Good | 30 (22) |
| Fair | 1 (1) |
| Poor | 0 |
| Medical conditions in adolescent | |
| Lung problems | 15 (11) |
| Neurologic problems | 4 (3) |
| Other chronic problem | 4 (3) |
| Allergy to eggs | 0 |
| None of the above | 78 (58) |
| Aware that there are vaccines recommended for this adolescent | 84 (62) |
aParents could answer questions about as many adolescents as they had in their family
Attitudes about vaccines among TeenVaxScene users
| Statement | % (n) agree or strongly agree |
|---|---|
| General attitudes, n = 65 | |
| I think vaccines may cause short-term problems (example: fever or pain) | 42 (27) |
| I think vaccines may cause serious long term health problems for [child’s name] | 15 (10) |
| Many of my friends are not getting their children vaccinated | 9 (6) |
| Having [child’s name]’s doctor recommend a vaccine is one of the most important factors in deciding to get [him/her] vaccinated | 69 (45) |
| I worry that vaccines may cause more health problems for [child’s name] than benefit | 20 (13) |
| HPV vaccine, n = 42 | |
| I worry that [child’s name] may be at risk for genital warts, [(female): cervical cancer or other cancers related to HPV] | 17 (7) |
| I worry that the HPV vaccine will give [child’s name] the HPV virus | 4 (2) |
| I worry that [child’s name] will have reproductive problems if he/she gets the HPV vaccine | 7 (3) |
| I worry that the HPV vaccine will cause immune problems for [child’s name] | 7 (3) |
| I worry that if [[child’s name] got the HPV vaccine, then [he/she] would get neurologic problems] or [his/her neurologic problems would worsen] | 9 (4) |
| I don’t think [my son] would get much benefit from getting the HPV vaccinea | 10 (2) |
| I think that giving the HPV vaccine to [child’s name] may make [him or her] think it is OK to have sexb | 23 (9) |
| I think [child’s name] is too young to get a vaccine for a sexually transmitted infection like HPVb | 23 (9) |
| I am concerned that the HPV vaccine costs more than I can payb | 13 (5) |
| The HPV vaccine is so new that I want to wait a while before deciding if [child’s name] should get itc | 27 (10) |
| I need more information about the HPV vaccine before deciding whether or not to give [child’s name] the vaccinec | 27 (10) |
| Many of my friends are against giving the HPV vaccine to adolescentsc | 7 (3) |
| I would regret it if [child’s name] did not get the vaccine and later got a health problem related to HPVc | 68 (25) |
| Tdap vaccine, n = 14 | |
| I worry that [child’s name] may get tetanus 1 day | 35 (5) |
| I worry that [child’s name] may be exposed to pertussis (whooping cough) | 43 (6) |
| I worry that the Tdap vaccine is not safe for [child’s name] | 21 (3) |
| I think that giving [child’s name] the Tdap vaccine is more harmful to [him/her] than not giving it | 21 (3) |
| I would have [child’s name] get the Tdap vaccine because it is required by [his/her] school | 64 (9) |
| Meningococcal vaccine, n = 22 | |
| I worry that [child’s name] may be at risk for getting meningitis | 14 (3) |
| I worry that the meningococcal vaccine is not safe for [child’s name] | 14 (3) |
| I think that giving [child’s name] the meningococcal vaccine is more harmful to [him/her] than not giving it | 10 (2) |
| I would have [child’s name] get the meningococcal vaccine because it is required by [his/her] school | 55 (12) |
| I worry that if [child’s name] got the meningococcal vaccine, then [[he/she] would get neurologic problems] or [his/her neurologic problems would worsen] | 10 (2) |
| Flu vaccine, n = 18 | |
| I worry that [child’s name] may be at risk for getting the flu | 24 (6) |
| I think the flu vaccine can cause [child’s name] to get the flu | 34 (6) |
| I worry that if [child’s name]got the flu vaccine [he/she would get neurologic problems or his/her neurologic problems would worsen] | 22 (4) |
| I don’t think the flu vaccine is safe | 16 (3) |
| It is a hassle to get this vaccine every year | 16 (3) |
| I think it is better for [child’s name] to have the flu than get the flu vaccine | 11 (2) |
The number of respondents changes for each section as parents were only asked about vaccines they reported their adolescent had not received previously. All parents received the general vaccination attitudes questions. Bracketed responses denote tailoring of the question to the child’s gender and/or neurologic status
aOnly respondents with sons were provided with this question, n = 19
bOnly 40 respondents answered this question
cOnly 37 respondents answered this question
Fig 1Participant flow through the various components of the TeenVaxScene intervention
Reported mean likelihood of having adolescent vaccinated before and after viewing TeenVaxScene
| Vaccine | N for analysis | Pre intervention mean | Post intervention mean | p value |
|---|---|---|---|---|
| HPV | 16 | 6.025 | 6.69 | 0.244 |
| Tdap | 4 | 8.00 | 8.00 | n/a |
| Meningococcal | 10 | 6.30 | 6.80 | 0.177 |
| Flu | 7 | 3.42 | 4.00 | 0.532 |
Analysis limited to participants who had data for both the pre-intervention and post-intervention surveys. The number of respondents varies by vaccine as parents were only asked to report on those vaccines they indicated their adolescent had not yet received
Impact of TeenVaxScene on planned vaccination behavior
| Vaccine | N for analysis | More likely to get | Don’t know | Less likely to get |
|---|---|---|---|---|
| HPV | 5 | 1 | 4 | 0 |
| Tdap | 3 | 2 | 1 | 0 |
| Meningococcal | 5 | 1 | 4 | 0 |
| Flu | 3 | 2 | 1 | 0 |
Data reported for parents who responded to the follow up survey 2 months after viewing TeenVaxScene, and indicated that their adolescent had still not received the given vaccine. The number of respondents varies by vaccine as parents were only asked to report on those vaccines they indicated their adolescent had not yet received
Impact of TeenVaxScene on vaccine uptake
| Utilizers | Non-utilizers | p value | |
|---|---|---|---|
| Tdap | 25 % (1/4) | 35 % (695/1965) | 0.99*** |
| Flu | 8 % (3/37) | 25 % (1690/6712) | 0.02 |
| MCV | 20 % (1/5) | 38 % (823/2162) | 0.66*** |
| HPV | 17 % (4/23) | 19 % (969/5004) | 0.99*** |
Among those eligible for the vaccine at the time of the visit, how many got a vaccine that day
Utilizers adolescents seen in the clinic during the study period whose parent used TeenVaxScene; Non-utilizers adolescents seen in the clinic during the study period whose parent did not use TeenVaxScene
*** Fisher’s exact test